Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Neurosurg ; 94(1): 97-101, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11147905

ABSTRACT

OBJECT: Glioblastomas multiforme (GBMs) grow rapidly and are highly resistant to treatment compared with other glioma types and grades. Consequently, it is of major interest to identify markers of aggressiveness in these tumors that could represent new therapeutic targets. Interleukin (IL)-6 is frequently produced in gliomas and, given its manifold properties, could be considered as a candidate marker. Expression of IL-6 may be involved in cell growth, resistance to chemotherapy and radiotherapy (via an antiapoptotic pathway), and angiogenesis. This study was conducted to test this hypotheses and to evaluate the suitability of IL-6 as a target in the treatment of GBMs. METHODS: The authors studied the relationship between the level of IL-6 gene expression as assessed using semiquantitative reverse transcription-polymerase chain reaction and by determining various histological types and grades in a series of 59 gliomas. It was found that GBMs displayed a significantly higher level of IL-6 expression than other types of glioma (p < 0.001). Immunohistochemical analysis revealed that IL-6 was produced mainly by malignant cells and a few vascular endothelial cells. CONCLUSIONS: It can be inferred from these findings that IL-6 gene expression is related to glioma aggressiveness and that IL-6 may play a central role in GBM behavior. Interleukin-6, therefore, could be considered as a new potential target in the treatment of GBMs.


Subject(s)
Central Nervous System Neoplasms/metabolism , Glioma/metabolism , Interleukin-6/metabolism , Aged , Biomarkers, Tumor/metabolism , Central Nervous System Neoplasms/genetics , Child , Gene Expression , Glioma/genetics , Humans , Immunohistochemistry , Interleukin-6/genetics , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction
2.
Acta Otolaryngol ; 120(8): 950-4, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11200590

ABSTRACT

Tumour growth of vestibular schwannomas is still difficult to predict. The aim of our study was to determine whether any defined histopathological feature was correlated with the clinical course. We did a retrospective study with 69 paraffin-embedded tumours to establish whether the number of vessels, blood cells extravasation or degree of inflammation, all semi-quantitatively assessed, could be indicative of potential of growth. An immunohistochemical study was also performed with an endothelial marker CD34, the leukocyte common antigen CD45 and the estrogen and progesterone hormone receptors. All these parameters were correlated with patient's age, duration of symptoms (d), with a clinical growth index (CLI = tumour size/d). No clinical parameters proved to be predictive of tumour growth. Tumour size was significantly (p = 0.01) related to the number of vessels and we found a significant relationship between the clinical growth index (CLI) and total number of vessels, especially when duration of symptoms lasted less than 1 year (p < 0.001). However, we found no relationship between duration of symptoms or CLI and CD34 index. The degree of inflammation was significantly correlated (p = 0.007) with duration of symptoms when it lasted more than 1 year. The CD45 index and the semi-quantitative evaluation of the inflammation were well correlated (p = 0.001). No estrogen receptors antigenic site was detected and only seven tumours expressed progesterone receptor in a few cells without any significant clinical value. These results suggest that vessel density is determinant for sporadic acoustic neuroma growth especially for a short clinical course.


Subject(s)
Ear Neoplasms/pathology , Neurilemmoma/pathology , Vestibule, Labyrinth , Adult , Aged , Female , Humans , Immunohistochemistry , Male , Middle Aged
3.
Int J Gynecol Pathol ; 17(1): 91-2, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9475200

ABSTRACT

Malignant mullerian mixed tumors of the uterine cervix are rare; <30 cases have been reported. We describe a new case in which the carcinomatous component was predominantly adenoid cystic carcinoma. Only one similar case has been reported.


Subject(s)
Carcinoma, Adenoid Cystic/pathology , Mixed Tumor, Mullerian/pathology , Uterine Cervical Neoplasms/pathology , Aged , Female , Humans
4.
Ann Pathol ; 17(2): 94-9, 1997 Apr.
Article in French | MEDLINE | ID: mdl-9221009

ABSTRACT

Lymphocytic mastitis is a non infectious inflammatory disease of the breast with lobulocentric lymphocytic infiltrate of variable intensity, collagenous fibrosis and progressive lobular atrophy. The pathogenesis of lymphocytic mastitis is still unknown but some recent reports have suggested an autoimmune origin. We investigated a series of 10 cases by immunohistochemistry and we collected patients' biologic data. The most striking histologic feature was a prominent lobulocentric stromal or intraepithelial lymphocytic infiltrate. Occasionally, the infiltrate was perivascular and nodular along the lobule border. B and T lymphocytes, both demonstrated by immunophenotypic analysis, were shown with a particular pattern of distribution. Pathologists must be aware of this disease in order to recommend immunological investigation.


Subject(s)
B-Lymphocytes/pathology , Mastitis/pathology , T-Lymphocytes/pathology , Adult , Female , Humans , Immunohistochemistry , Immunophenotyping , Mastitis/immunology , Mastitis/metabolism , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...